NasdaqGM:TMDXMedical Equipment
TransMedics Group (TMDX) Q1 EPS Lull Tests Bullish Profitability Narratives
Q1 2026 earnings snapshot
TransMedics Group (TMDX) has just posted Q1 2026 results with revenue of US$173.9 million, basic EPS of US$0.21 and net income of US$7.3 million, set against a current share price of US$72.92. The company has reported revenue of US$121.6 million in Q4 2024 and US$173.9 million in Q1 2026, while quarterly basic EPS moved from US$0.20 to US$0.21 over the same span. With trailing earnings growth and a higher net profit margin in the background, this quarter’s numbers...